May 22 2013
Roche presents new, fully automated lab solution at Europe's largest diagnostics conference
more
May 18 2013
Roche's etrolizumab meets primary endpoint of clinical remission in moderate to severely active ulcerative colitis at week 10
more
Roche maintains open and honest relationships with our shareholders, prospective investors and the wider investment community. The role of Investor Relations is to manage these relationships efficiently, transparently and consistently in accordance with company polices and relevant securities rules and laws.
IR Mission & Goals
Roche's ADR (American Depositary Receipt) is listed on OTCQX International Premier under the symbol RHHBY. Traded in U.S. Dollars, one (1) Roche ADR represents one quarter (1/4) of one underlying non-voting equity security (Genussschein, abbreviated NES).
ADR Information
Roche Facts & Figures for U.S. Investors
Roche ADR Backgrounder
Roche ADR Dividend Reinvestment Program